They developed what might be the first cancer vaccine

If by “they” you mean Russia, that’s not what your source says. It’s a press release about Agenus (a US company) licensing their vaccine for production and sale in Russia.

they have entered into a license, development and manufacturing technology transfer agreement for Agenus’ Oncophage® (HSPPC-96; vitespen) vaccine